| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10909574 | Leukemia Research | 2005 | 5 Pages |
Abstract
This elevated mRNA expression most probably contributes to the frequently found aberrant hypermethylation in MDS and might explain the promising clinical response of MDS patients treated with DNMT inhibitors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Florian Länger, Jens Dingemann, Hans Kreipe, Ulrich Lehmann,